Various vaccine antigens and co-adjuvants

Various vaccine antigens and co-adjuvants is a collective term referring to the primary active components used in vaccine formulations to elicit a protective immune response. Antigens are the specific molecular structures, such as viral proteins, inactivated pathogens, or synthetic mRNA, that define the target of the immune response and allow the adaptive immune system to develop memory against a particular pathogen (Source: CDC, “Vaccine Ingredients”). Co-adjuvants are pharmacological or immunological agents added to the vaccine to modify or augment the immune response to the antigen, often by activating innate immune sensors like Toll-like receptors (TLRs) to provide the “danger signals” required for robust lymphocyte activation (Source: NIH, “Vaccine Adjuvants”). Together, these components work to induce long-lasting immunity, including the production of high-affinity antibodies and the generation of memory T and B cells. Because this term encompasses a vast array of distinct molecular entities rather than a single biological receptor or enzyme, it is classified as a functional category of drug components rather than a specific therapeutic target.

Other names

Vaccine componentsAntigen-adjuvant systemsImmunogens and adjuvants

Antigens provide specific epitopes for adaptive immune recognition by B and T cells, while co-adjuvants stimulate innate immune pathways, such as Toll-like receptors (TLRs) or the NLRP3 inflammasome, to enhance antigen presentation and provide necessary costimulatory signals (Source: PubMed, PMID: 30635915).